Literature DB >> 9865205

Persistent keratoacanthoma: challenges in management.

G C Canas1, K J Robson, C J Arpey.   

Abstract

BACKGROUND: Keratoacanthoma is a common cutaneous neoplasm, although the persistent form is less common and often more difficult to manage. Multiple treatment approaches have been attempted with variable efficacy. Establishing the diagnosis and selecting a treatment plan for persistent keratoacanthoma is often challenging.
OBJECTIVE: Our purpose is to describe the difficulty one may encounter in the diagnosis and treatment of persistent keratoacanthoma. Hopefully, review of this clinical conundrum may facilitate the management of the reader's future patients.
METHODS: We describe a case of persistent keratoacanthoma where the diagnosis was initially elusive and the management challenging. Our thought process during each stage of diagnosis and management is described in the form of "issues" with references to the appropriate literature.
RESULTS: After several diagnostic and therapeutic interventions, successful treatment was achieved with administration of oral isotretinoin. Long-term remission continued as the dosage was tapered.
CONCLUSION: Persistent keratoacanthoma may be challenging to diagnose and manage, presenting a clinical conundrum. Careful review of the clinicopathologic presentation and an understanding of the various treatment options may result in a successful outcome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865205     DOI: 10.1111/j.1524-4725.1998.tb00016.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  3 in total

1.  Recurrent facial keratoacanthoma in a patient with diabetes: a case report.

Authors:  Esam Omar
Journal:  BMC Res Notes       Date:  2014-04-23

2.  Eruptive keratoacanthomatous atypical squamous proliferations (KASPs) arising in skin graft sites.

Authors:  Melanie A Clark; Joan Guitart; Pedram Gerami; Benjamin R Marks; Sapna Amin; Simon S Yoo
Journal:  JAAD Case Rep       Date:  2015-07-29

3.  Immunohistochemical evaluation of p53 and Ki67 expression in skin epithelial tumors.

Authors:  Effat Khodaeiani; Ashraf Fakhrjou; Mehdi Amirnia; Shahla Babaei-Nezhad; Farshid Taghvamanesh; Elham Razzagh-Karimi; Hossein Alikhah
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.